Manuscripts
Showing 1552 manuscripts.
In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.
Citation
Susan Brogly, Paige L. Williams, George Seage, Lynne M. Mofenson, Russell B. Van Dyke, James M. Oleske. In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.. Journal of Acquired Immune Deficiency Syndromes. 2006. 41: 535-536.Year
2006
Journal
Journal of Acquired Immune Deficiency Syndromes
Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the U.S.
Citation
Kumud K. Singh, Michael Hughes, Jie (Ellen) Chen, Stephen A. Spector. Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the U.S.. AIDS. 2006. 20: 475-478.Year
2006
Journal
AIDS
Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
Citation
Paige L. Williams, Deborah S. Storm, Grace Montepiedra, Sharon L. Nichols, Betsy Kammerer, Patricia Sirois, John J. Farley, Kathleen Malee. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.. Pediatrics. 2006. 118: e1745 - e1757. PMID: 17101712Year
2006
Journal
Pediatrics
Reduced lopinavir exposure during pregnancy.
Citation
Edmund Capparelli, Brookie M. Best, ChengCheng Hu, Sandra K. Burchett, Carol Elgie, Diane T. Holland, Elizabeth Smith, Ruth Tuomala, Amanda Cotter, Jennifer S. Read, Alice M. Stek, Mark Mirochnick. Reduced lopinavir exposure during pregnancy.. AIDS. 2006. 20: 1931 - 1939. PMID: 16988514Year
2006
Journal
AIDS
Study
P1026S
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Citation
Mark J. Abzug, Stephen Ira Pelton, Lin-Ye Song, Terence Fenton, Myron Levin, Sharon Appelbaum Nachman, William Borkowsky, Howard Max Rosenblatt, John F. Marcinak, Arry Dieudonne, Elaine J. Abrams, Indu Pathak. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.. Pediatric Infectious Disease Journal. 2006. 25: 920 - 929. PMID: 17006288Year
2006
Journal
Pediatric Infectious Disease Journal
Study
P1024
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection
Citation
Jason T. Blackard, Minhee Kang, Kenneth E. Sherman, Margaret James Koziel. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of Interferon and Cytokine Research. 2006. 26: 834-8.Year
2006
Journal
Journal of Interferon and Cytokine Research
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy
Citation
M. Atif Siddique, Kelly E. Hartman, Elvira Dragileva, Marla Silman, Tebeb Gebretsadik, Ayumi Shintani, Laurence Peiperl, Fred T. Valentine, Spyros A. Kalams. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. Journal of Infectious Diseases. 2006. 194: 661-5.Year
2006
Journal
Journal of Infectious Diseases
Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency
Citation
Marek J Nowicki, Sarah Palmer, Elias (Lou) K. Halvas, Ranier Ziermann, Grace M. Aldrovandi, Richard Y. Zhao, Peter Balfe, Cheryl L. Jennings, Ingrid A. Beck, James W. Bremer, Valerie F. Boltz, Donald J. Brambilla, John Coffin, John W. Mellors, Lisa M. Frenkel, J. Darren Hazelwood, Victoria A. Johnson, Mary Kearney, Andrea Kovacs, Daniel R. Kuritzkes, Karin J. Metzner, Dwight V. Nissley. Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. Journal of Clinical Microbiology. 2006. 44: 2612-4.Year
2006
Journal
Journal of Clinical Microbiology
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
Citation
Ronald J. Bosch, Ronald T. Mitsuyasu, J. Michael Kilby, R. Pat Bucy, Donna Mildvan, Margaret A. Fischl, Jorge L. Santana, Jeffrey L. Lennox, Christopher D. Pilcher, Andrew R. Zolopa, Jody Lawrence, Richard B. Pollard, Rafaelle El-Habib, David Sahner, Lawrence Fox, Evgenia Aga. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).. Journal of Infectious Diseases. 2006. 194: 1672-6. PMID: 17109338Year
2006
Journal
Journal of Infectious Diseases
Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells
Citation
Tracey King, Lane R. Bushman, Jennifer J. Kiser, Peter Anderson, M. Graham Ray, Tom Delahunty, Courtney V. Fletcher. Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences. 2006. 843: 147-56.Year
2006
Journal
Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences